Swine Artificial Insemination Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
Swine Artificial Insemination Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Equipment, Semen, Reagent, Kit, Service), By Distribution Channel (Private, Public), By End User (Hospitals, Clinics, Others), By Region & Competition, 2021-2031F
報告摘要
Market Overview
The Global Swine Artificial Insemination Market is projected to expand significantly from USD 2.21 Billion in 2025 to USD 3.23 Billion by 2031, achieving a 6.53% CAGR. This assisted reproductive technology, involving the manual delivery of collected boar semen into a sow's reproductive tract for fertilization, is driven by a critical need for genetic optimization to ensure superior meat quality and minimize disease transmission risks associated with natural mating. Additionally, the economic benefits derived from reducing the number of resident boars and maximizing sow output support its widespread adoption, with China's breeding sow inventory reaching 40.43 million head in June 2025, underscoring the scale of operations reliant on efficient breeding protocols. The market's primary catalyst is the rising global consumption of pork and the corresponding demand for high-quality animal protein, compelling producers to use artificial insemination for rapidly disseminating superior genetic traits across commercial herds, ensuring uniformity in meat quality and maximizing output to meet international export requirements, exemplified by robust U.S. pork exports. The expansion of large-scale industrialized swine operations further cements AI's dominance, as these farms prioritize biosecurity, maintain closed herds to minimize disease entry, and leverage precision genetics to optimize feed conversion ratios and herd resilience, a trend reflected in the strong financial performance of major genetic providers.
Market Driver
The increasing global demand for pork and high-quality animal protein is a primary catalyst, as consumer preference for lean, consistent, and safe meat products drives producers to adopt artificial insemination to rapidly disseminate superior genetic traits across commercial herds. This ensures uniformity in meat quality and maximizes protein output per sow, vital for meeting international export requirements; for instance, U.S. pork exports surged to 3.03 million metric tons valued over $8.63 billion in February 2025. The expansion of large-scale, industrialized commercial swine operations further reinforces AI's role, as these farms prioritize biosecurity and operational efficiency by utilizing AI to maintain closed herds and minimize the entry of transboundary diseases that can be transmitted through live boars. Moreover, these entities leverage precision genetics to optimize feed conversion ratios and herd resilience, a shift towards high-tech breeding reflected in the £111.9 million adjusted operating profit of Genus plc's porcine division (PIC) in 2025 and Brazil's projected market share expansion to 15% of global pork volumes, driven by advanced breeding protocols.
Market Challenge
A formidable barrier to the global artificial insemination market's expansion is the susceptibility of swine populations to transboundary diseases like African Swine Fever. Severe outbreaks necessitate mass depopulation of infected and exposed herds, directly reducing the inventory of breeding sows available for insemination and causing an immediate contraction in demand for semen doses and services. Furthermore, strict quarantine protocols and movement restrictions enforced to contain these diseases sever the logistical lines essential for the industry, as AI relies heavily on the time-sensitive delivery of fresh boar semen through a stable cold chain. Regional lockdowns often halt these transport networks, as seen with Vietnam's over 970 ASF outbreaks affecting more than 100,000 pigs in July 2025. Consequently, the unpredictability of such biological threats hampers long-term investment and limits the consistent adoption of insemination technologies, alongside the requirement for skilled technicians to perform the procedure and manage cold chain logistics, which acts as a significant barrier in developing regions with limited infrastructure.
Market Trends
The market is experiencing a structural shift towards the consolidation into large-scale centralized boar stud operations, driven by the need for economies of scale in high-health genetic production. Genetic providers are merging assets to pool resources for enhanced biosecurity and research, replacing smaller, fragmented collection centers with industrial-grade facilities. This centralization enables tighter control over disease vectors and more efficient distribution networks, favoring entities capable of sustaining high capital investments, as evidenced by Topigs Norsvin's turnover exceeding €300 million in 2025, driven by strategic expansion of integrated operations. Simultaneously, the application of genomic selection in commercial AI programs is revolutionizing the value proposition of semen doses by quantifying economically important traits. Advanced breeding programs now utilize vast datasets to predict and disseminate traits such as feed efficiency and survival rates more rapidly than traditional phenotypic selection, ensuring that each insemination dose delivers measurable financial returns to pork producers through enhanced herd performance, with DanBred's genomic program achieving an annual breeding progress valued at EUR 2.48 per finisher pig in 2025.
Key Market Players
* Genus plc
* IMV Technologies SADIR
* Shipley Swine Genetics
* Agtech Inc
* Neogen Corp
* Genpro Inc
* Minitub GmbH
* Swine Genetics International
* Hypor BV
* Semen Cardona
Report Scope
In this report, the Global Swine Artificial Insemination Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# Swine Artificial Insemination Market, By Product
* Equipment
* Semen
* Reagent
* Kit
* Service
# Swine Artificial Insemination Market, By Distribution Channel
* Private
* Public
# Swine Artificial Insemination Market, By End User
* Hospitals
* Clinics
* Others
# Swine Artificial Insemination Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Swine Artificial Insemination Market.
Available Customizations:
Global Swine Artificial Insemination Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Swine Artificial Insemination Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Equipment, Semen, Reagent, Kit, Service)
5.2.2. By Distribution Channel (Private, Public)
5.2.3. By End User (Hospitals, Clinics, Others)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. North America Swine Artificial Insemination Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Distribution Channel
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Swine Artificial Insemination Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Distribution Channel
6.3.1.2.3. By End User
6.3.2. Canada Swine Artificial Insemination Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Distribution Channel
6.3.2.2.3. By End User
6.3.3. Mexico Swine Artificial Insemination Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Distribution Channel
6.3.3.2.3. By End User
7. Europe Swine Artificial Insemination Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Distribution Channel
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Swine Artificial Insemination Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Distribution Channel
7.3.1.2.3. By End User
7.3.2. France Swine Artificial Insemination Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Distribution Channel
7.3.2.2.3. By End User
7.3.3. United Kingdom Swine Artificial Insemination Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Distribution Channel
7.3.3.2.3. By End User
7.3.4. Italy Swine Artificial Insemination Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Distribution Channel
7.3.4.2.3. By End User
7.3.5. Spain Swine Artificial Insemination Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Distribution Channel
7.3.5.2.3. By End User
8. Asia Pacific Swine Artificial Insemination Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Distribution Channel
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Swine Artificial Insemination Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Distribution Channel
8.3.1.2.3. By End User
8.3.2. India Swine Artificial Insemination Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Distribution Channel
8.3.2.2.3. By End User
8.3.3. Japan Swine Artificial Insemination Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Distribution Channel
8.3.3.2.3. By End User
8.3.4. South Korea Swine Artificial Insemination Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Distribution Channel
8.3.4.2.3. By End User
8.3.5. Australia Swine Artificial Insemination Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Distribution Channel
8.3.5.2.3. By End User
9. Middle East & Africa Swine Artificial Insemination Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Distribution Channel
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Swine Artificial Insemination Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Distribution Channel
9.3.1.2.3. By End User
9.3.2. UAE Swine Artificial Insemination Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Distribution Channel
9.3.2.2.3. By End User
9.3.3. South Africa Swine Artificial Insemination Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Distribution Channel
9.3.3.2.3. By End User
10. South America Swine Artificial Insemination Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Distribution Channel
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Swine Artificial Insemination Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Distribution Channel
10.3.1.2.3. By End User
10.3.2. Colombia Swine Artificial Insemination Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Distribution Channel
10.3.2.2.3. By End User
10.3.3. Argentina Swine Artificial Insemination Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Distribution Channel
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Swine Artificial Insemination Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Genus plc
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. IMV Technologies SADIR
15.3. Shipley Swine Genetics
15.4. Agtech Inc
15.5. Neogen Corp
15.6. Genpro Inc
15.7. Minitub GmbH
15.8. Swine Genetics International
15.9. Hypor BV
15.10. Semen Cardona
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們